You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Low grade serous ovarian carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Low Grade Serous Ovarian Carcinoma and Uterine Involvement :

Completed
  • Serous Ovarian Carcinoma
  • Low Grade Serous Ovarian Carcinoma
  • Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.
  • Lyon, France
    Hospices civils de Lyon
Feb 14, 2023

Low Grade Serous Ovarian Carcinoma, Adult Type Granulosa Cell Tumor Trial in Gent, Leuven, Liège (Abemaciclib, Letrozole)

Not yet recruiting
  • Low Grade Serous Ovarian Carcinoma
  • Adult Type Granulosa Cell Tumor
  • Gent, Oost-Vlaanderen, Belgium
  • +2 more
May 12, 2023

Low Grade Serous Ovarian Cancer Trial (avutometinib + defactinib, Investigator Choice of Treatment (ICT))

Not yet recruiting
  • Low Grade Serous Ovarian Cancer
  • avutometinib + defactinib
  • Investigator Choice of Treatment (ICT)
  • (no location specified)
Oct 2, 2023

Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary Trial in Brescia, Genova (Letrozole tablets, carboplatin

Recruiting
  • Carcinoma, Ovarian Epithelial
  • Low Grade Serous Adenocarcinoma of Ovary
  • Letrozole tablets
  • carboplatin AUC 5 and paclitaxel 175 mg/m2
  • Brescia, BS, Italy
  • +1 more
Oct 26, 2022

Patients With Low Grade Ovarian or Peritoneal Tumors

Recruiting
  • Low Grade Ovarian Serous Adenocarcinoma
  • +5 more
  • Biospecimen Collection
  • Electronic Health Record Review
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

Recruiting
  • Fallopian Tube Carcinosarcoma
  • +28 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
Sep 2, 2022

Ovarian Carcinoma Trial (PEP-DC1, OC-DC, PEP-DC2)

Not yet recruiting
  • Ovarian Carcinoma
  • PEP-DC1
  • +3 more
  • (no location specified)
Jan 26, 2023

Ovarian Cancer, Serous Ovarian Cancer Trial in Pittsburgh (Regorafenib, Fulvestrant)

Not yet recruiting
  • Ovarian Cancer
  • Serous Ovarian Cancer
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute
Apr 17, 2022

Outcomes in Patients With Low-grade Serous Ovarian Cancer

Recruiting
  • Low-grade Serous Ovarian Carcinoma
  • Recurrent Invasive Borderline Serous Ovarian Cancer
    • Napoli, Italy
      Istitute Nazionale Tumori - Fondazione G. Pascale
    Mar 3, 2021

    Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid

    Not yet recruiting
    • Recurrent Endometrial Carcinoma
    • +8 more
    • BET Bromodomain Inhibitor ZEN-3694
    • +7 more
    • (no location specified)
    Jul 15, 2023

    Malignant Solid Tumor, Ovarian Low Grade Serous Adenocarcinoma, Pancreatic Carcinoma Trial (Binimetinib, Biopsy, Biospecimen

    Not yet recruiting
    • Malignant Solid Neoplasm
    • +4 more
    • (no location specified)
    Nov 8, 2022

    Ovarian Cancer Trial in Worldwide (VS-6766, VS-6766 and Defactinib)

    Recruiting
    • Low Grade Ovarian Serous Adenocarcinoma
    • Ovarian Cancer
    • avutometinib (VS-6766)
    • avutometinib (VS-6766) and Defactinib
    • Scottsdale, Arizona
    • +46 more
    Dec 29, 2022

    Granulosa Cell Ovarian Cancer, Low Grade Serous Ovarian/ Primary Peritoneal Cancer, Endometrioid Endometrial Cancer Trial in

    Recruiting
    • Granulosa Cell Ovarian Cancer
    • +2 more
    • Onapristone ER
    • Onapristone ER + Anastrozole
    • Basking Ridge, New Jersey
    • +7 more
    Aug 17, 2022

    Malignant Tumors of Female Genital Organs Trial in Houston (Fulvestrant, Abemaciclib)

    Active, not recruiting
    • Malignant Neoplasms of Female Genital Organs
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 5, 2022

    High Grade Serous Ovarian Cancer (HGSOC) Trial (FAPI PET CT)

    Not yet recruiting
    • High Grade Serous Ovarian Cancer (HGSOC)
    • FAPI PET CT
    • (no location specified)
    Jul 20, 2023

    High Grade Serous Adenocarcinoma of Ovary, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (Sovilnesib)

    Not yet recruiting
    • High Grade Serous Adenocarcinoma of Ovary
    • +3 more
    • (no location specified)
    Oct 13, 2023

    Ovarian Cancer, Relapsed Ovarian Cancer, Fallopian Tube Cancer Trial (Carboplatin)

    Not yet recruiting
    • Ovarian Cancer
    • +6 more
    • (no location specified)
    Oct 27, 2022

    Low Grade Serous Carcinoma Trial in United States (Ribociclib, Letrozole)

    Recruiting
    • Low Grade Serous Carcinoma
    • San Francisco, California
    • +26 more
    Feb 15, 2022

    New Prognostic Index for Neoadjuvant Chemotherapy Outcome in

    Enrolling by invitation
    • Ovarian Cancer
    • +2 more
    • CRS scoring
    • Routine blood laboratory testing before treatment
    • Guangzhou, Guangdong, China
      The Sun Yat-sen Memorial Hospital of Sun Yat-sen University
    Nov 2, 2023

    CINSARC Genomic Signature as Predictor of Resectability of

    Completed
    • Ovarian Adenocarcinoma
    • CINSARC signature
    • Toulouse, France
      Institut Claudius Regaud Institut Universitaire du cancer Toulou
    Dec 22, 2022

    High Grade Serous Ovarian Cancer Trial in Montpellier (Blood sample and tissue sample)

    Not yet recruiting
    • High Grade Serous Ovarian Cancer
    • Blood sample and tissue sample
    • Montpellier, France
      NOUGARET Stephanie
    Oct 10, 2023

    Investigate Adaptation and Evolution of Ovarian High-grade

    Recruiting
    • Ovarian Cancer
    • +6 more
      • Bristol, United Kingdom
      • +10 more
      Sep 8, 2022

      NSCLC, Low Grade Serous Ovarian Cancer, Endometrioid Carcinoma Trial in United Kingdom (VS-6766, Defactinib)

      Recruiting
      • NSCLC
      • +3 more
      • Manchester, Greater Manchester, United Kingdom
      • +4 more
      Mar 18, 2022

      Ovarian Cancer, Stage III Ovarian Cancer, Stage IV Ovarian Cancer Trial in Toronto (Niraparib)

      Not yet recruiting
      • Ovarian Cancer
      • +3 more
      • Toronto, Ontario, Canada
        Sunnybrook Research Institute
      Jul 18, 2023

      Chromosomal Instability in Ovarian Cancer

      Recruiting
      • Epithelial Ovarian Cancer
      • +7 more
      • Testing for chromosomal instability (CIN)
      • Beijing, Beijing, China
        Lei Li
      Mar 26, 2022